{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:08:56Z","timestamp":1761588536061,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109784","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T05:47:46Z","timestamp":1676872066000},"page":"109784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Side effects of Sputnik V, Oxford\u2013AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran"],"prefix":"10.1016","volume":"117","author":[{"given":"Sahar","family":"Oghazian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taraneh","family":"Tavanaei Tamanaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojdeh","family":"Faregh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Bagher","family":"Oghazian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10242","key":"10.1016\/j.intimp.2023.109784_b0005","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2023.109784_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18020778","article-title":"Value of Immunizations during the COVID-19 Emergency","volume":"18","author":"Stefanati","year":"2021","journal-title":"Int. J. Environ. Res. Public Health."},{"issue":"7","key":"10.1016\/j.intimp.2023.109784_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of covid-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.109784_b0020","first-page":"263","article-title":"Risk Factors for COVID-19 infection among healthcare workers. a first report from a living systematic review and meta-analysis. saf health","volume":"13","author":"Dzinamarira","year":"2022","journal-title":"Work"},{"issue":"5","key":"10.1016\/j.intimp.2023.109784_b0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/oemed-2020-106731","article-title":"Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants","volume":"78","author":"Mutambudzi","year":"2020","journal-title":"Occup Environ Med."},{"key":"10.1016\/j.intimp.2023.109784_b0030","first-page":"6","article-title":"Challenges, inquiry, and recommendations: effective COVID-19 vaccine management in the face of public mistrust and concern","author":"Caron","year":"2021","journal-title":"Front Commun."},{"key":"10.1016\/j.intimp.2023.109784_b0035","article-title":"Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review","volume":"9","author":"Joshi","year":"2021","journal-title":"Front public Heal."},{"issue":"1","key":"10.1016\/j.intimp.2023.109784_b0040","doi-asserted-by":"crossref","first-page":"19832","DOI":"10.1038\/s41598-022-23825-2","article-title":"COVID-19 vaccine acceptance rates and predictors among the Egyptian general population and Healthcare workers, the intersectionality of age and other factors","volume":"12","author":"El-Ghitany","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109784_b0045","doi-asserted-by":"crossref","first-page":"05027","DOI":"10.7189\/jogh.11.05027","article-title":"A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries","volume":"11","author":"Moola","year":"2021","journal-title":"J Glob Health."},{"issue":"1","key":"10.1016\/j.intimp.2023.109784_b0050","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s12913-022-07948-w","article-title":"Acceptance of COVID-19 vaccine and determinant factors in the Iranian population: a web-based study","volume":"22","author":"Omidvar","year":"2022","journal-title":"BMC Health Serv. Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.109784_b0055","first-page":"12","article-title":"Identifying Strategies to Boost COVID-19 Vaccine Acceptance in the United States","volume":"9","author":"Schmitzberger","year":"2022","journal-title":"Rand Heal Q."},{"unstructured":"Adverse Events Following Immunization (AEFI) [Internet]. [cited 2022 Dec 30]. Available from: https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and-safety\/pharmacovigilance\/health-professionals-info\/aefi.","key":"10.1016\/j.intimp.2023.109784_b0060"},{"issue":"1","key":"10.1016\/j.intimp.2023.109784_b0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.109784_b0070","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1473-3099(20)30942-7","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial","volume":"21","author":"Ella","year":"2021","journal-title":"Lancet Infect Dis."},{"issue":"7","key":"10.1016\/j.intimp.2023.109784_b0075","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1473-3099(21)00070-0","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial","volume":"21","author":"Ella","year":"2021","journal-title":"Lancet Infect Dis."},{"issue":"10267","key":"10.1016\/j.intimp.2023.109784_b0080","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet (London, England)."},{"issue":"10269","key":"10.1016\/j.intimp.2023.109784_b0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet (London, England)."},{"issue":"10275","key":"10.1016\/j.intimp.2023.109784_b0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.intimp.2023.109784_b0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First Month of COVID-19 Vaccine Safety Monitoring \u2014 United States, December 14, 2020\u2013January 13, 2021","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"9","key":"10.1016\/j.intimp.2023.109784_b0100","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.ymthe.2021.08.001","article-title":"A comprehensive analysis of the efficacy and safety of COVID-19 vaccines","volume":"29","author":"Cai","year":"2021","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2023.109784_b0105","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.4103\/jfmpc.jfmpc_2370_21","article-title":"Acceptance and adverse effects following COVID-19 vaccination among the health care workers at a health care centre in the most backward district of India","volume":"11","author":"Sharma","year":"2022","journal-title":"J. Fam. Med. Prim. care."},{"issue":"6","key":"10.1016\/j.intimp.2023.109784_b0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhqr.2021.05.002","article-title":"COVID-19 vaccination among Spanish nephrologists: acceptance and side effects","volume":"36","author":"Quiroga","year":"2021","journal-title":"J. Healthc. Qual. Res."},{"unstructured":"Possible Side Effects After Getting a COVID-19 Vaccine [Internet]. [cited 2021 Feb 10]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/expect\/after.html.","key":"10.1016\/j.intimp.2023.109784_b0115"},{"unstructured":"WHO Coronavirus (COVID-19) Dashboard: WHO: World Health Organization; 2021. Available from: https:\/\/covid19.who.int\/.","key":"10.1016\/j.intimp.2023.109784_b0120"},{"key":"10.1016\/j.intimp.2023.109784_b0125","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1744-6570.1975.tb01393.x","article-title":"A quantitative approach to content validity","volume":"28","author":"Lawshe","year":"1975","journal-title":"Pers Psychol."},{"key":"10.1016\/j.intimp.2023.109784_b0130","series-title":"Handbook of Mobile Technology Research Methods","first-page":"31","article-title":"Design of a questionnaire","author":"Brinkman","year":"2009"},{"issue":"4","key":"10.1016\/j.intimp.2023.109784_b0135","first-page":"341","article-title":"Is the CVI an acceptable indicator of content validity?","volume":"31","author":"Polit","year":"2008","journal-title":"Appraisal and recommendations. Res. Nurs. Health."},{"issue":"3","key":"10.1016\/j.intimp.2023.109784_b0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem. medica."},{"issue":"3","key":"10.1016\/j.intimp.2023.109784_b0145","first-page":"14","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"81","author":"General Assembly of the World Medical Association","year":"2014","journal-title":"J. Am. Coll. Dent."},{"issue":"1","key":"10.1016\/j.intimp.2023.109784_b0150","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12879-022-07411-5","article-title":"Adverse effects following COVID-19 vaccination in Iran","volume":"22","author":"Babaee","year":"2022","journal-title":"BMC Infect. Dis."},{"doi-asserted-by":"crossref","unstructured":"M. Klugar, A. Riad, M. Mekhemar, J. Conrad, M. Buchbender, H-P. Howaldt, et al., Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers, Biology (Basel). 10 (8) (2021 Aug 5) 752. DOI: https:\/\/doi.org\/10.3390\/biology10080752.","key":"10.1016\/j.intimp.2023.109784_b0155","DOI":"10.3390\/biology10080752"},{"issue":"1","key":"10.1016\/j.intimp.2023.109784_b0160","doi-asserted-by":"crossref","first-page":"21464","DOI":"10.1038\/s41598-021-00963-7","article-title":"Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran","volume":"11","author":"Babamahmoodi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109784_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101027","article-title":"ROCCA observational study: early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance","volume":"38","author":"Montalti","year":"2021","journal-title":"EClinicalMedicine."},{"issue":"3","key":"10.1016\/j.intimp.2023.109784_b0170","first-page":"408","article-title":"Active monitoring of early safety of Sputnik V vaccine in Buenos Aires","volume":"81","author":"Pagotto","year":"2021","journal-title":"Argentina. Med. (B Aires)"},{"key":"10.1016\/j.intimp.2023.109784_b0175","article-title":"Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city","volume":"101","author":"Zare","year":"2021","journal-title":"Iran. Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109784_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.760047","article-title":"BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees","volume":"8","author":"Alghamdi","year":"2021","journal-title":"Front Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.109784_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10030366","article-title":"Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: a large-scale multinational study implementing machine learning tools in predicting post-vaccination adverse effects based on predisposing factors","volume":"10","author":"Hatmal","year":"2022","journal-title":"Vaccines."},{"doi-asserted-by":"crossref","unstructured":"I. Iguacel, A.L. Maldonado, A.L. Ruiz-Cabello, M. Casaus, L.A. Moreno, B. Mart\u00ednez-Jarreta, Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain, Vaccines. 9 (11) (2021 Nov 15) 1321. DOI: https:\/\/doi.org\/10.3390\/vaccines9111321.","key":"10.1016\/j.intimp.2023.109784_b0190","DOI":"10.3390\/vaccines9111321"},{"issue":"6","key":"10.1016\/j.intimp.2023.109784_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9060577","article-title":"Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines","volume":"9","author":"Abu-Hammad","year":"2021","journal-title":"Vaccines."},{"key":"10.1016\/j.intimp.2023.109784_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108906","article-title":"Adverse events following COVID-19 vaccination: a systematic review and meta-analysis","volume":"109","author":"Kouhpayeh","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109784_b0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijid.2021.08.013","article-title":"Side effects and perceptions following Sinopharm COVID-19 vaccination","volume":"111","author":"Saeed","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.109784_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102207","article-title":"Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study","volume":"15","author":"Almufty","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"unstructured":"The Oxford\/AstraZeneca (ChAdOx1-S [recombinant] vaccine) COVID-19 vaccine: what you need to know [Internet]. [cited 2022 Dec 30]. Available from: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know.","key":"10.1016\/j.intimp.2023.109784_b0215"},{"key":"10.1016\/j.intimp.2023.109784_b0220","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.2147\/IDR.S332354","article-title":"Adverse effects of the COVID-19 vaccine reported by lecturers and staff of kabul university of medical sciences, Kabul","volume":"14","author":"Azimi","year":"2021","journal-title":"Afghanistan. Infect. Drug Resist."},{"issue":"2","key":"10.1016\/j.intimp.2023.109784_b0225","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000519456","article-title":"Adverse events following astrazeneca COVID-19 vaccine in saudi arabia: a cross-sectional study among healthcare and nonhealthcare workers","volume":"65","author":"Alghamdi","year":"2022","journal-title":"Intervirology"},{"issue":"17","key":"10.1016\/j.intimp.2023.109784_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3346\/jkms.2021.36.e114","article-title":"Adverse events following immunization associated with coronavirus disease 2019 vaccination reported in the mobile vaccine adverse events reporting system","volume":"36","author":"Jeon","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.intimp.2023.109784_b0235","first-page":"124","article-title":"Adverse events of Oxford\/AstraZeneca's COVID-19 vaccine among health care workers of Ayder Comprehensive Specialized Hospital, Tigray","volume":"1","author":"Tequare","year":"2021","journal-title":"Ethiopia. IJID Reg."},{"key":"10.1016\/j.intimp.2023.109784_b0240","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.2147\/JMDH.S331140","article-title":"Covid-19 vaccine: Side effects after the first dose of the oxford astrazeneca vaccine among health professionals in low-income country: Ethiopia","volume":"14","author":"Solomon","year":"2021","journal-title":"J. Multidiscip. Healthc."},{"issue":"7","key":"10.1016\/j.intimp.2023.109784_b0245","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.109784_b0250","doi-asserted-by":"crossref","first-page":"e0265140","DOI":"10.1371\/journal.pone.0265140","article-title":"The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers","volume":"17","author":"Desalegn","year":"2022","journal-title":"Cross sectional survey. PLoS One."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2023.109784_b0255","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1016\/j.mjafi.2021.06.014","article-title":"Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: a prospective observational study","volume":"77","author":"Kamal","year":"2021","journal-title":"Med. j., Armed Forces India."},{"issue":"3","key":"10.1016\/j.intimp.2023.109784_b0260","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/cmi.cmi_50_21","article-title":"How safe is Covishield (ChAdOx1nCoV-19) Vaccine? experience from a Tertiary Care Hospital in South India","volume":"19","author":"Inbaraj","year":"2021","journal-title":"Curr Med Issues."},{"issue":"39","key":"10.1016\/j.intimp.2023.109784_b0265","article-title":"The how's and what's of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"npj Vaccines"},{"issue":"4","key":"10.1016\/j.intimp.2023.109784_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040393","article-title":"Analysis of thrombotic adverse reactions of COVID-19 AstraZeneca vaccine reported to eudravigilance database","volume":"9","author":"Tobaiqy","year":"2021","journal-title":"Vaccines."},{"issue":"6","key":"10.1016\/j.intimp.2023.109784_b0275","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/jmv.27655","article-title":"Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India","volume":"94","author":"Parida","year":"2022","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.intimp.2023.109784_b0280","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1111\/jdv.18150","article-title":"Cutaneous adverse effects of the available COVID-19 vaccines in India: a questionnaire-based study","volume":"36","author":"Bawane","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109784_b0285","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-022-00453-5","article-title":"Use of analgesics\/antipyretics in the management of symptoms associated with COVID-19 vaccination","volume":"7","author":"Ooi","year":"2022","journal-title":"npj. Vaccines"},{"issue":"1","key":"10.1016\/j.intimp.2023.109784_b0290","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1186\/s12889-022-13575-1","article-title":"Study protocol: cohort event monitoring for safety signal detection after vaccination with COVID-19 vaccines in Iran","volume":"22","author":"Aliyari","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.intimp.2023.109784_b0295","article-title":"Protocol template to be used as template for observational study protocols: cohort event monitoring (CEM) for safety signal detection after vaccination with COVID-19 vaccines","author":"World Health Organization","year":"2021","journal-title":"World Health Organization. [Internet]. Available from"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:05:01Z","timestamp":1761588301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":59,"alternative-id":["S1567576923001078"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109784","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side effects of Sputnik V, Oxford\u2013AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109784"}}